BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31351673)

  • 1. Genotype-phenotype associations in Fanconi anemia: A literature review.
    Fiesco-Roa MO; Giri N; McReynolds LJ; Best AF; Alter BP
    Blood Rev; 2019 Sep; 37():100589. PubMed ID: 31351673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thinking of VACTERL-H? Rule out Fanconi Anemia according to PHENOS.
    Alter BP; Giri N
    Am J Med Genet A; 2016 Jun; 170(6):1520-4. PubMed ID: 27028275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort.
    Altintas B; Giri N; McReynolds LJ; Best A; Alter BP
    Haematologica; 2023 Jan; 108(1):69-82. PubMed ID: 35417938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype.
    Asur RS; Kimble DC; Lach FP; Jung M; Donovan FX; Kamat A; Noonan RJ; Thomas JW; Park M; Chines P; Vlachos A; Auerbach AD; Smogorzewska A; Chandrasekharappa SC
    Mol Genet Genomic Med; 2018 Jan; 6(1):77-91. PubMed ID: 29193904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of clinical severity with FANCB variant type in Fanconi anemia.
    Jung M; Ramanagoudr-Bhojappa R; van Twest S; Rosti RO; Murphy V; Tan W; Donovan FX; Lach FP; Kimble DC; Jiang CS; Vaughan R; Mehta PA; Pierri F; Dufour C; Auerbach AD; Deans AJ; Smogorzewska A; Chandrasekharappa SC
    Blood; 2020 Apr; 135(18):1588-1602. PubMed ID: 32106311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients.
    Freire BL; Homma TK; Funari MFA; Lerario AM; Leal AM; Velloso EDRP; Malaquias AC; Jorge AAL
    Eur J Med Genet; 2018 Mar; 61(3):130-133. PubMed ID: 29133208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic analysis of Japanese patients with Fanconi anemia: novel findings].
    Mori M; Yabe H; Yabe M; Takata M
    Rinsho Ketsueki; 2019; 60(6):691-701. PubMed ID: 31281162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fanconi anemia: causes and consequences of genetic instability.
    Kalb R; Neveling K; Nanda I; Schindler D; Hoehn H
    Genome Dyn; 2006; 1():218-242. PubMed ID: 18724063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in
    Reyes P; García-de Teresa B; Juárez U; Pérez-Villatoro F; Fiesco-Roa MO; Rodríguez A; Molina B; Villarreal-Molina MT; Meléndez-Zajgla J; Carnevale A; Torres L; Frias S
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
    Kalb R; Neveling K; Hoehn H; Schneider H; Linka Y; Batish SD; Hunt C; Berwick M; Callen E; Surralles J; Casado JA; Bueren J; Dasi A; Soulier J; Gluckman E; Zwaan CM; van Spaendonk R; Pals G; de Winter JP; Joenje H; Grompe M; Auerbach AD; Hanenberg H; Schindler D
    Am J Hum Genet; 2007 May; 80(5):895-910. PubMed ID: 17436244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fanconi anemia and DNA repair.
    Grompe M; D'Andrea A
    Hum Mol Genet; 2001 Oct; 10(20):2253-9. PubMed ID: 11673408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should chromosome breakage studies be performed in patients with VACTERL association?
    Faivre L; Portnoï MF; Pals G; Stoppa-Lyonnet D; Le Merrer M; Thauvin-Robinet C; Huet F; Mathew CG; Joenje H; Verloes A; Baumann C
    Am J Med Genet A; 2005 Aug; 137(1):55-8. PubMed ID: 16015582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
    Keupp K; Hampp S; Hübbel A; Maringa M; Kostezka S; Rhiem K; Waha A; Wappenschmidt B; Pujol R; Surrallés J; Schmutzler RK; Wiesmüller L; Hahnen E
    Mol Genet Genomic Med; 2019 Sep; 7(9):e863. PubMed ID: 31347298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss-of-Function FANCL Mutations Associate with Severe Fanconi Anemia Overlapping the VACTERL Association.
    Vetro A; Iascone M; Limongelli I; Ameziane N; Gana S; Della Mina E; Giussani U; Ciccone R; Forlino A; Pezzoli L; Rooimans MA; van Essen AJ; Messa J; Rizzuti T; Bianchi P; Dorsman J; de Winter JP; Lalatta F; Zuffardi O
    Hum Mutat; 2015 May; 36(5):562-8. PubMed ID: 25754594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.